Clinical Trials Browser

Pleural Effusion, Malignant × Sorafenib × Clear all

NCT00533585 2016-02-10

BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion, Malignant